SEATTLE, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Attorney Advertisement Material. Keller Rohrback L.L.P., Keller Rohrback P.L.C., Pogust Braslow Millrood LLC and Deskin Law Firm, a PLC filed a class action lawsuit today against Eli Lilly and Company ("Lilly") (NYSE:LLY). Lilly, an Indiana based pharmaceutical company, is the maker of Cymbalta. The class action complaint was filed in the United States District Court for the Central District of California, in Los Angeles, on behalf of all consumers who purchased Cymbalta at any time since the product's launch in August 2004 to the present.
Cymbalta is prescribed to individuals that have been diagnosed with generalized anxiety disorder, fibromyalgia, and musculoskeletal pain. Plaintiff alleges that Lilly misrepresented the risks associated with taking Cymbalta and misled consumers about the frequency, severity, and duration of "Cymbalta withdrawal." Withdrawal symptoms include, among others, headaches, dizziness, nausea, fatigue, nightmares, insomnia, anxiety, and suicidal ideation. Cymbalta withdrawal symptoms can range from mild to severe—the latter consisting of debilitating and painful symptoms that last several months.
If you used Cymbalta or you would like more information regarding the Cymbalta class action, please contact one of the following attorneys: Michael Woerner or Mark Samson, Keller Rohrback at 800-776-6044 or via e-mail at consumer@kellerrohrback.com.
If you used Cymbalta, suffered serious side effects, and want more information about pursuing an individual personal injury claim, please contact Pogust Braslow Millrood LLC and Deskin Law Firm, a PLC via the contact form on the website: http://cymbaltasideeffects.com or at 800-897-8930 or via email at cymbalta@deskinlawfirm.com.